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ABSTRACT: Designer particles that are embued with nano-
machinery for autonomous motion have great potential for
biomedical applications; however, their development is highly
demanding with respect to biodegradability/compatibility. Pre-
viously, biodegradable propulsive machinery based on enzymes has
been presented. However, enzymes are highly susceptible to
proteolysis and deactivation in biological milieu. Biodegradable
hybrid nanomotors powered by catalytic inorganic nanoparticles
provide a proteolytically stable alternative to those based upon
enzymes. Herein we describe the assembly of hybrid biodegradable nanomotors capable of transducing chemical energy into motion.
Such nanomotors are constructed through a process of compartmentalized synthesis of inorganic MnO2 nanoparticles (MnPs)
within the cavity of organic stomatocytes. We show that the nanomotors remain active in cellular environments and do not
compromise cell viability. Effective tumor penetration of hybrid nanomotors is also demonstrated in proof-of-principle experiments.
Overall, this work represents a new prospect for engineering of nanomotors that can retain their functionality within biological
contexts.
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Engineering of motile vehicles at the micro- and nanoscalewith built-in systems of chemical propulsion has witnessed
a surge of interest over the past decade.1−4 In such systems,
autonomous motion is achieved by the conversion of chemical
energy into kinetic energy.5,6 Such chemical processes are
empowered by various forms of bio-organic and inorganic
catalysts (e.g., enzymes and platinum nanoparticles).7,8 The
potential of motile materials in biomedical research (by, e.g.,
facilitating the active transport of biofunctional cargo) has
been presented as a key opportunity for the exploitation of this
technology.9−11 Indeed, developing robust chemistries that can
give rise to motility and diverse structural architectures that
form the molecular chassis for these vehicles drives fascinating
progress toward the actual translation of these systems.12−15 In
particular, controlling physical properties such as particle
morphology and composition is essential to expand the
motors’ potential in applications that can benefit from non-
Brownian motility.16−19 Developing micro- and nanomotors
suitable for biomedical integration has been explored by
various research groups, who have demonstrated motors’
capability in undertaking complex tasks.20−23 Stad̈ler et al.
showed the capacity of microswimmers for directed
penetration of three-dimensional (3D) cell spheroids, offering
a wealth of opportunities for the application of micro- and
nanomotors in tissue penetration and cargo/drug delivery.24
Recently, the group of Sen showed the ability of liposome
protocells to undergo positive and negative chemotaxis
behavior, unlocking tremendous opportunities for biological
transport.25 Such systems not only demonstrate the advanta-
geous aspects of non-Brownian motility within biological
contexts but also highlight the challenges faced in engineering
of new features for such complex materials and emphasize the
importance of molecular interactions between the motors and
their environmenta significant aspect for their effective
function and application.
Miniaturization of motile systems to the nanoscale is
extremely challenging, but it is critical for their development
toward biomedical applications by facilitating effective
interactions with cells and tissues while avoiding the
unfavorable fate of microscopic particles (e.g., poor circulation
and distribution).26,27 Developing both the nanomotor chassis
and propulsive unit for biodegradability and compatibility
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while preventing unwanted deactivation by inevitable environ-
mental factors (e.g., the presence of proteolytic enzymes) is an
important milestone toward the widespread adoption of such
materials. Dual-compartmentalized stomatocytes, which are
bowl-shaped polymersomes,28,29 are uniquely suited for
nanomotor fabrication because of their asymmetric structure
with an internal cavity (or stomach) that is in direct contact
with the external environment via a tunable neck. In our
previous work, we have showcased the potential of such
stomatocytes to function as nanomotors by encapsulating
enzymatic cargo to drive their mechanical motion;30,31
however, that work utilized nondegradable polystyrene block
copolymers (BCPs) that, without doubt, lack any immediate
biomedical relevance. The motility of such systems using
enzymatic cargo was achieved by modulating the size of the
opening (or neck) during encapsulation so that the macro-
molecular cargo could be effectively sequestered, preventing
unwanted release or digestion by external proteases. From that
work, the capacity of stomatocytes to confine and protect
biocatalysts in their stomach, allowing enzymatic reactions to
take place that can drive motility in complex biological media,
was apparent. Capitalizing on that research, our group has
developed biodegradable stomatocytes by employing well-
defined poly(ethylene glycol)-block-poly(D,L-lactide) (PEG−
PDLLA) BCPs.32,33 Such PDLLA-based stomatocytes were
effectively integrated into biomedical research through, for
example, incorporation of photosensitizers and surface coating
with cell membrane components.34 On the basis of these
developments, biodegradable stomatocyte nanomotors with
enzymes covalently tethered in their cavity have been
reported.35 However, as the neck size of these motors was
not controlled, the protection capacity was lost, leaving
incorporated enzymes exposed to proteolytic deactivation
severely limiting, if not withholding, their application in
biological contexts.
Building on these recent developments and the considerable
capacity of stomatosomal architectures, exploiting the unique
structure of PDLLA stomatocytes as nanomotors that can
function within biological contexts holds great future potential
for biomedical applications. To this end, in the present work
we employed inorganic nanoparticles as robust catalytic
nanomachinery that can drive the stomatocytes’ thrust in
harsh proteolytic media. Inorganic catalysts, such as manganese
dioxide (MnO2), have found application in, for example,
cancer therapy.36−38 In general, such nanoparticles are
generated through surface stabilization or in situ formation
using protein or polymer nanostructures,39,40 making hybrid
architectures. As MnO2 is capable of catalase-mimetic catalytic
decomposition of hydrogen peroxide (H2O2) into water and
oxygen (to drive motion through nanobubble formation), it is
a suitable candidate to replace enzymes as the propulsive units
for our biodegradable/compatible stomatocyte nanomotors.
Figure 1. (A) Schematic demonstrating the formation of spherical polymersomes and their subsequent osmotic-induced shape transformation into
stomatocytes. (B) Schematic demonstrating the compartmentalized synthesis of MnPs within the stomatocytes’ lumen and subsequent formation of
hybrid nanomotors that can convert fuel into mechanical motion. (C) Cryo-TEM image of an empty stomatocyte. (D) Cryo-TEM image of a
MnP-loaded stomatocyte. (E) 3D rendering of a MnP-loaded stomatocyte obtained by TEM tomography. Scale bars = 200 nm.
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Furthermore, the utility of MnO2 particles as contrast agents
has recently been shown through in vivo studies.41 In fact,
researchers have recently pointed out the broad potential of
enzyme-like inorganic particles for biomedical applications, as
they hold interesting advantages: higher catalytic stability, ease
of modification/functionalization, lower manufacturing costs
compared with enzymes, utility as multimodal platforms, and
remote control by external cues (magnetic fields, light,
etc.).42,43 In this paper, we demonstrate the ability of
PDLLA stomatocytes to be used for the compartmentalized
synthesis of MnO2, a strategy that results in highly effective
functional integration that yields fully biodegradable and
biocompatible nanomotors that are not vulnerable to
enzymatic deactivation in complex biological media. Using
advanced characterization techniques, we explore the structure
of hybrid nanomotors and demonstrate their enhanced motion,
stability against protease deactivation, degradability, and
compatibility with cells. In this way, this work demonstrates
a novel concept for the design principles of a nanomotor
platform that is primed for further application in biomedical
research. In doing so, we also showcase a robust approach for
the synthesis of inorganic catalysts using a compartmentaliza-
tion approach to support the fabrication of complex,
multifunctional nanoarchitectures.
Stomatocyte nanomotors were assembled from the bottom-
up utilizing biodegradable copolymers comprising 1 and 2 kDa
PEG and PDLLA (n = 95). Such copolymers were synthesized
via organo-catalyzed ring-opening polymerization following
our previously published procedure (Supporting Information
(SI) section S2, Figures S1 and S2, and Table S1).33 Solvent-
induced supramolecular self-assembly of amphiphilic PEG−
PDLLA into polymersomes was performed using equimolar
blends of both copolymers in organic solvent (10 wt % in
THF/dioxane, 1:4 v/v) followed by controlled addition of an
equal volume of Milli-Q water. The shape transformation of
spherical polymersomes into bowl-shaped stomatocytes was
then achieved by applying an osmotic pressure on the
plasticized membrane through dialysis against 75 mM NaCl
at 4 °C (Figure 1A,C). Tailoring the salt concentration during
dialysis can, to a certain extent, tune the neck size of such
stomatocytes through increased deflation and consequent
volume reduction. Under the conditions employed, an average
neck size of 94 ± 50 nm was achieved; this is ca. 15 times
larger than the size of a protein like bovine serum albumin
(BSA). The formation of such stomatocytes was monitored
and confirmed using dynamic light scattering (DLS), nano-
tracking analysis (NTA), and cryogenic transmission electron
microscopy (cryo-TEM) (Figure S3).
Encapsulation of active components into the PDLLA-based
stomatocyte cavity is a challenging task. One example where
this is most apparent is the covalent approach adopted by the
group of Wilson to localize enzymes in the stomatocytes’
cavity;35 however, controlling such complex, multistep,
functionalization steps remains elusive and necessitates
alternative strategies. Inspired by previous examples showing
the controlled growth of inorganic nanoparticles as an effective
strategy for their inclusion in organic materials (e.g., protein
and polymer cages),44 we developed a non-covalent approach
based on the compartmentalized synthesis of inorganic MnO2
nanoparticles (MnPs) within the organic stomatocytes as an
effective one-pot pathway for catalyst loading and subsequent
construction of hybrid nanomotors. As evidenced by TEM
tomographic analysis, our approach exploited the unique
structural features of stomatocytes by utilizing their inner
nanocompartment as a 3D template for the synthesis of
inorganic MnPs that would be more readily entrapped within
this domain and not escape through the 94 nm neck (Figures
1E and S4 and Videos S1 and S2). This compartmentalized
synthesis of MnPs was achieved by dissolving potassium
permanganate (KMnO4) in the stomatocyte solution for 1 h
prior to reduction using sodium thiosulfate (Na2S2O3). BSA
was added to stabilize the resulting colloidal dispersion and to
prevent uncontrolled aggregation. In this way, MnPs were
formed and compartmentalized within the stomatocyte,
whereas non-entrapped particles were removed readily using
centrifugation (Figures 1B,D, S5, and S6). It is noteworthy that
diverse types of preformed nanoparticles, including MnPs,
could not be physically encapsulated within the cavity of
PDLLA stomatocytes, as observed in initial trials (Figure S7).
Therefore, the in situ synthesis/growth of MnO2 nanoparticles
within the stomatocyte cavity was necessary for the successful
realization of our hybrid nanomotor system. Cryo-TEM
imaging and 3D tomographic reconstruction confirmed the
well-defined nature of the resulting hybrid architectures
(Figures 1D,E, S4, and S5 and Videos S1 and S2).
Interestingly, although the average size of individual MnPs
was ca. 25 nm (Figure S8), fractionally smaller than the
apparent size of the neck, the high density of particles inside
the stomach seemed to create a retaining force to prevent their
escape, as observed from images from cryo-TEM and
tomographic analysis (Figures 1E, S4, and S5 and Videos S1
and S2). Analysis of tomography data indicated the formation
of nanoaggregates/agglomerates (i.e., particles attached to each
other) with sizes larger than the neck of the stomatocytes
(Figures 1C and S4 and Videos S1 and S2). Therefore, escape
of such nanoparticles from the inner cavity did not occur, even
after 3 months. Remarkably, the size of such nanoaggregates
was significantly larger than that of the nanoparticles grown
outside the stomatocytes. This can be attributed to a
templating effect: the stomatocytes’ nanocavity templates the
growth of the MnO2 nanoparticles. This same effect was
previously observed in the case of either in situ-grown
nanoparticles or the assembly of enzymes in polystyrene-
based stomatocytes.30,31,45 Such a difference in the sizes of
nanoparticles formed inside and outside of the stomatocytes
can be due to the difference in nanoparticle growth rate. The
low volume of the stomatocyte nanocavity compared with the
outer solution could result in the formation of fewer nucleation
centers and hence larger particles. This is in agreement with
previous reports that demonstrate the relationship between
nanoparticle size and the concentration of both the inorganic
salt and capping agent.45 This approach is general and would
be applicable to the compartmentalized synthesis of a range of
metal/metal oxide nanoparticles, with the open neck
permitting the flux of molecular substrates, preventing
coalescence/aggregation while facilitating application in
processing methods such as microfluidics because of the
overall size of the compartment.
In order to study the ability of our hybrid stomatocytes to
undergo autonomous motion, NTA was used to record the
nanomotors’ movement and track their trajectories as MnPs
catalyzed the formation of O2. In general, O2-driven propulsion
is mediated by fuel decomposition and subsequent formation
of nanobubbles that propel the particle through their release
from the motor’s chassis. The asymmetric structure of
stomatocytes, with a unidirectional neck, are particularly suited
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to exploit this bubble-propelled motion. This is indeed
reflected by their propulsion, which was found to be
proportional to the concentration of H2O2 (Figure 2A and
Video S3). The mean square displacements (MSDs) and
velocities of such hybrid stomatocyte nanomotors were
analyzed using Golestanian’s self-diffusiophoretic model (the
detailed analysis is described in SI section S2).46 The range of
observed MSD values for hybrid stomatocytes upon addition
of an increasing concentration of fuel reflects the inherent
polydispersity in terms of MnO2 loading achieved in this
system (Figure S9). Although one would expect linear fits of
the MSD curves at relatively high Δt (because of the short self-
rotation time τr of such small nanoparticles), nonlinear fits
were identified at high concentrations of fuel (Figure 2B).
Indeed, analysis of the anomalous diffusive exponent (α) value
after addition of fuel showed an increase, which suggests an
enhanced superdiffusion (propulsive) behavior (Figure S10).
These results suggest that the autonomous movement of such
nanomotors is a consequence of the bubble generation
mechanism, which counteracts, to a certain extent, the effect
of the short τr. Nevertheless, effects of such a short τr on the
motors’ motion can be clearly seen in the shape of the
nondirectional trajectories (Figure 2C). In order to confirm
that the autonomous motion is a result of the catalytic process
that takes place within the nanomotor cavity, control
experiments were performed. First, a high concentration of
H2O2 (100 mM) was added to unloaded stomatocytes. This
did not result in any autonomous motion, and all of the
stomatocytes maintained their Brownian motion (Figure S11A
and Video S4). Further controls in which empty stomatocytes
were combined with free MnPs in solution yielded no motion,
indicating the importance of catalyst spatial positioning within
the stomatocytes (Figure S11B and Video S5).
To highlight the robust nature of these nanomotors, we
studied their performance over time. To do so, nanomotors
were tested on their ability to be reactivated upon fuel
depletion (Figure 2D). After 3 days and over the course of
three cycles of fuel addition and depletion, no change in their
diffusion coefficient was recorded (as measured by NTA),
indicating the stability of this hybrid nanomotor system and
that the MnP platform is a highly suitable and robust catalytic
nanomachine that is not degraded after a single use. Finally,
the motility of our hybrid nanomotors was tested in a
proteolytic environment, namely, in the presence of proteinase
K at a concentration of 50 μg mL−1 (30 units mg−1). At first
sight, interestingly, it was clear that the Brownian motion of
the stomatocyte nanomotors in the absence of fuel was
impacted by the presence of proteinase K, with a ca. 2-fold
lower MSD (Figure 2E). This is likely due to normal protein
interaction with the stomatocytes’ surface, which leads to an
increase in the overall particle size and thus slower Brownian
motion (as evidenced by the ca. 150 nm increase in
Figure 2. (A) Schematic demonstrating the spatial positioning of catalytic MnPs within stomatocytes, MnPs’ capacity to convert a range of fuel
concentrations into O2 nanobubbles, and the (hypothesized) mechanism by which motion occurs. (B) MSD and velocity of hybrid nanomotors in
the presence of a range of H2O2 concentrations. The velocities were theoretically calculated from MSD = (4D)Δt + (v2)(Δt2). NTA measurements
were performed by diluting MnP-loaded stomatocytes (1:1000) in 1× PBS ([polymer] = 5 μg mL−1). Thereafter, aliquots of H2O2 were added (to
reach a final concentration of 5, 25, or 50 mM). (C) Tracked Brownian and non-Brownian trajectories in the absence and presence of fuel,
respectively. (D) Diffusion coefficients of MnP-loaded stomatocytes as a result of multiple cycles of fuel addition and depletion. In order to ensure
complete depletion of fuel, the time interval between experiments (fuel addition) was 1 day. (E) MSDs of hybrid stomatocytes exposed to 50 μg
mL−1 proteinase K (dotted line).
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hydrodynamic size; Figure S12). This hypothesis was also
confirmed by measurement of the MSD of empty carriers in
the presence of proteinase K at the same concentration (50
μM), where a similar effect was observed (Figure S13). Despite
this, the nanomotors’ autonomous motion was clearly
maintained in the presence of fuel, and only a slight reduction
in the MSD was observed (compared to measurements
without free proteins), highlighting the stability of this system
and its relevance for application in a biological context. Taken
together, these studies demonstrate the robust properties of
our hybrid nanomotor compared with the more sensitive
catalysts generally used in nanoscale motile systems.
To assess the potential of hybrid nanomotors for application
in biomedical research, we first demonstrated the degradation
of the MnP catalyst by glutathione (GSH), an intracellular
antioxidant. In general, GSH is present at micromolar
concentrations within the plasma, although this increases to
millimolar levels within the cell. At high concentrations of
GSH (10 mM), a significant color change was directly
observed within 1 min (Figure 3A). The degradation of the
MnP catalyst was also confirmed by the nanomotors’
deactivation and consequent recovery of their Brownian
motion upon GSH addition (Figure 3B). Motor activity
under less severe conditions (10 μM GSH) was not affected in
the same time frame (Figure S15). These studies indicated that
under certain intracellular conditions (e.g., elevated reductant
concentration) nanomotors would be deactivated. In fact,
developing glutathione-responsive systems has been regarded
as an appealing strategy for targeted drug delivery in cancer
cells.47,48 Taking into account the potential use of nanomotors
as drug nanocarriers, this would be advantageous, as such
systems would have autonomous motion in the extracellular
environments but be degraded at the target.
In our final set of experiments, we performed cellular testing
using nanomotors to assess their biocompatibility and ability to
function in a cellular environment. Particle toxicity was
measured using HeLa cells treated with empty and loaded
stomatocytes up to 250 μg mL−1 for 24 h (Figure 4A and
Table S2). Relatively low toxicity was observed for hybrid
nanomotors at 250 μg mL−1 in comparison with other
nanomotor systems that displayed similar (ca. 80%) viability
at lower concentrations.49 When cells were treated with toxic
concentrations of H2O2 of either 125 or 250 μM in the
presence of unloaded stomatocytes, no population of viable
cells was visible (Figure S16). To assess the ability of
nanomotors to function under such conditions of low fuel
levels, we conducted additional motion studies at H2O2
concentrations equivalent to those employed in the cell studies
(i.e., 125 and 250 μM). Under such conditions, enhanced
diffusion was observed, and the hybrid nanomotors retained
their motile properties (Figure S17). H2O2 is a cytotoxic
species that is generated at increasing concentrations in the
tumor microenvironment and in cancerous cells; for instance,
Guo and co-workers determined H2O2 levels of around 715
μM in bladder cancer tissues.41 Because of their ability to
scavenge H2O2, harnessing it for their enhanced diffusion,
nanomotors were utilized to rescue the viability of cells during
exposure to this harmful oxidative species. Indeed, around 50%
viability was obtained after treatment of cells (exposed to 125
μM H2O2) with nanomotors at 125 μg mL
−1 (Figure 4B and
Table S3). This significantly increased to ca. 80% when the
nanomotor concentration was elevated to 250 μg mL−1, near
the background level as presented in Figure 4A. At an elevated
H2O2 concentration of 250 μM, cell viability recovered up to
ca. 45% because of the performance limits of the nanomotor.
To validate that the nanomotor-mediated increase in cellular
viability was commensurate with decreasing reactive oxygen
species (ROS) levels, additional experiments were performed
using a fluorescent ROS indicator (CM-H2DCFDA). Confocal
microscopy (and quantitative analysis) confirmed that under
the most extreme conditions (250 μM/250 μg mL−1), cellular
ROS was significantly reduced in the presence of hybrid
nanomotors compared with unloaded stomatocytes, which did
not have a significant effect (Figures 4C−E, S18, and S19).
Although this effect was very pronounced, this only correlated
to a partial recovery in viability, as shown in Figure 4B.
As a proof-of-principle experiment, we compared the
penetration behavior of fluorescently labeled hybrid nano-
motors and empty stomatocytes in 3D cell spheroids (the
Figure 3. (A) Visual of MnO2 catalyst (MnP) reduction by addition
of high levels of glutathione (GSH) (10 mM) to a 10-fold dilution of
MnPs in 1× PBS, where decoloration within 1 min indicates
dissolution of the MnP catalyst. (B) Diffusion coefficients for fueled
nanomotors before and after GSH addition, showing motor
deactivation at high levels of GSH even after repeated fuel addition.
Fuel was added at a final concentration of 100 mM. The diffusion
coefficient for passive particles is lower than those presented in Figure
2 because of batch-to-batch differences in size distribution (Figure
S14).
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experiments were conducted in triplicate using 250 μM H2O2;
Figures 4F,G and S20−S22). A nuclear cell stain (Hoechst)
was used to provide an indication of overall spheroid
morphology, where treatment with 250 μM H2O2 did not
compromise cell stability (compared with those cultured in
two dimensions), in agreement with the literature that reports
higher toxicity resistance of 3D cell models compared with 2D
ones (Figure S20).50,51 We observed that nanomotors (fueled
by H2O2) penetrated effectively into the spheroid, whereas
control particles showed significantly reduced infiltration of the
dense cellular framework. These data highlight the applicability
of our technology and provide proof-of-principle results to
guide future biomedical studies.
In summary, we have presented a new strategy for the
fabrication of biodegradable hybrid stomatocyte nanomotors.
The unique structural features of such stomatocytes were
utilized to template the in situ one-pot preparation of a
biodegradable MnO2 catalytic core through a process of
compartmentalized synthesis. Such hybrid nanomotors show
autonomous motion in the presence of fuel and maintain their
stability through extended periods of time. Moreover, such
nanomotors maintained their activity in physiological medium
and are highly biocompatibleable to reduce local ROS levels
to protect cells. This system has strong potential in biomedical
research and highlights the capacity of molecular engineering
for the creation of morphologically diverse, functional
nanosystems. To further showcase this application, we
conducted proof-of-principle experiments to demonstrate
effective penetration of nanomotors into 3D cell spheroids.
Future research will engage the utility of compartmentalized
inorganic nanocatalysts (and assorted stabilizing molecules) to
drive autonomous (nano)motion and explore their biorelated
applications. We believe that our approach can offer a general
route toward assembling functional nanomotors and paves the
way to overcome limitations associated with traditional
physical encapsulation of active catalysts. Further studies will
expand the range of nanoparticles that can be integrated within
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Figure 4. (A) Viability of HeLa cells after exposure to empty and MnP-loaded stomatocytes at a range of concentrations (15−250 μg mL−1) as
determined by MTT assay. (B) Hybrid stomatocytes rescue the viability of HeLa cells after coincubation with H2O2. (C) ROS induction (as
indicated by the green fluorescence of CM-H2DCFDA stain) in HeLa cells after treatment with H2O2 is significantly reduced by the presence of
hybrid nanomotors (blue = Hoechst nuclear stain; scale bar = 50 μm). (F) Penetration of empty stomatocytes and (G) hybrid nanomotors into 3D
cell spheroids (coincubated with 250 μM H2O2) with accompanying line profiles for comparison (experiments were replicated in triplicate, cf.
Figures S21 and S22; scale bars = 1 mm).
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Surface view from cryo-TEM tomography of MnP-
loaded stomatocytes showing the overall structure of the
nanomotor (MP4)
Cryo-TEM tomography of MnP-loaded stomatocytes
showing the structure of the MnO2 nanoparticles inside
the cavity of the nanomotor (MP4)
Compilation of NTA videos of motile MnP-loaded
stomatocytes in the presence of fuel (MP4)
NTA video of empty stomatocytes in the presence of
fuel (MP4)
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